The potential for isoenzyme-selective modulation of protein kinase C

FASEB Journal

Volumn 11, Issue 8, 1997, Pages 649-669

  Hofmann, Johann ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Inhibitory peptides; Isoenzyme selective inhibitors; Substrate peptides

Indexed keywords

ISOENZYME; PROTEIN KINASE C;

ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME SPECIFICITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030762437     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.11.8.9240967     Document Type: Review

References (256)

1. Inoue, M., Kishimoto, A., Takai, Y., and Nishizuka, Y. (1977) Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues II. J. Biol. Chem. 252, 7610-7616
2. Hug, H., and Sarre, T. F. (1993) Protein kinase C isoenzymes: divergence in signal transduction? Biochem. J. 291, 329-343
3. Jaken, S. (1996) Protein kinase C isozymes and substrates. Curr. Opin. Cell Biol. 8, 168-173
4. Johannes, F.-J., Prestle, J., Eis, S., Oberhagemann, P., and Pfizenmaier, K. (1994) PKCθ is a novel atypical member of the protein kinase C family. J. Biol. Chem. 269, 6140-6148
5. Stabel, S., and Parker, P. J. (1991) Protein kinase C. Pharmacol. & Ther. 41, 71-95
6. Stabel, S. (1994) Protein kinase C - an enzyme and its relatives. Semin. Cancer Biol. 5, 277-284
7. Azzi, A., Boscoboinik, D., and Hensey, C. (1992) The protein kinase C and protein kinase C related gene families. Eur. J. Biochem. 208, 547-557
8. Nishizuka, Y. (1995) Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 9, 484-496
9. Mochly-Rosen, D. (1995) Localization of protein kinases by anchoring proteins: a theme in signal transduction. Science 268, 247-251
10. Olivier, A. R., and Parker, P. J. (1994) Bombesin, platelet-derived growth factor, and diacylglycerol induce selective membrane association and down regulation of protein kinase C isotypes in Swiss 3T3 cells. J. Biol. Chem. 269, 2758-2763
11. Ha, K. S., and Exton, J. H. (1993) Differential translocation of protein kinase C isozymes by thrombin and platelet-derived growth factor. A possible function for phosphatidylcholine-derived diacylglycerol. J. Biol. Chem. 268, 10534-10539
12. Hannun, Y. A., Obeid, L. A., and Wolff, R. A. (1993) The novel second messenger ceramide: identification, mechanism of action, and cellular activity. Adv. Lipid Res. 25, 43-64
13. Clerk, A., Bogoyevitch, M. A., Andersson, M. B., and Sugden, P. H. (1994) Differential activation of protein kinase C isoforms by endothelin-1 and phenylephrine and subsequent stimulation of p42 and p44 mitogen-activated protein kinases in ventricular myocytes cultured from neonatal rat hearts. J. Biol. Chem. 269, 32848-32857
14. Goss, V. L., Hocevar, B. A., Thompson, L. J., Stratton, C. A., Burns, D. J., and Fields, A. P. (1994) Identification of nuclear βII protein kinase C as a mitotic lamin kinase. J. Biol. Chem. 269, 19074-19080
15. Hannun, Y. A., and Bell, R. M. (1989) Regulation of protein kinase C by sphingosine and lysosphingolipids. Clin. Chim. Acta 185, 333-345
16. Nakanishi, H., Brewer, K. A., and Exton, J.H. (1993) Activation of the z isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 268, 13-16
17. Clark, K. J., and Murray, A. W. (1996) Evidence that the bradykinin-induced activation of phospholipase D and the mitogen-activated kinase cascade involve different protein kinase C isoforms. J. Biol. Chem. 270, 7097-7103
18. Szallasi, Z., Smith, C. B., Pettit, G. R., and Blumberg, P. M. (1994) Differential regulation of protein kinase C isozymes by bryostatin 1 and phorbol 12-myristate 13-acetate in NIH 3T3 fibroblasts. J. Biol. Chem. 269, 2118-2124
19. Chapline, C., Ramsay, K., Klauck, T., and Jaken S. (1993) Interaction cloning of protein kinase C substrates. J. Biol. Chem. 268, 6858-6861
20. Liao, L., Hyatt, S. L., Chapline, C., and Jaken, S. (1994) Protein kinase C domains involved in interactions with other proteins. Biochemistry 33, 1220-1233
21. Hyatt, S. L., Liao, L., Chapline, C., and Jaken, S. (1994) Identification and characterization of α-protein kinase C binding proteins in normal and transformed REF52 cells. Biochemistry 33, 1223-1228
22. Kiley, S. C., and Jaken, S. (1994) Protein kinase C: interactions and consequences. Trends Cell Biol. 4, 223-227
23. Dong, L., Chapline, C., Mousseau, B., Fowler, L., Ramsay, K., Stevens, J. L., and Jaken, S. (1995) 35H, a sequence isolated as a protein kinase C binding protein, is a novel member of the adducin family. J. Biol. Chem. 270, 25534-25540
24. Blobe, G. C., Obeid, L. M., and Hannun, Y. A. (1994) Regulation of protein kinase C and role in cancer biology. Cancer Metastasis Rev. 13, 411-431
25. Niedel, J. E., Kuhn, L. J., and Vandenbark, G. R. (1983) Phorbol diester receptor copurifies with protein kinase C. Proc. Natl. Acad. Sci. USA 80, 36-40
26. Housey, G. M., Johnson, M. D., Hsiao, W. L. W., O'Brian, C. A., Murphy, J. P., Kirshmeier, P., and Weinstein, I. B. (1988) Overproduction of protein kinase C causes disordered growth control in rat fibroblasts. Cell 52, 343-354
27. Finkenzeller, G., Marme, D., and Hug, H. (1992) Inducible overexpression of human protein kinase C in NIH 3T3 fibroblasts results in growth abnormalities. Cell. Signalling 4, 163-177
28. Persons, D. A., Wilkinson, W. O., Bell, R. M., and Finn, O. J. (1988) Altered growth regulation and enhanced tumorigenicity of NIH 3T3 fibroblasts transfected with protein kinase C-I cDNA. Cell 52, 447-458
29. Blobe, G. C. (1996) Protein kinase C isoenzymes, regulation and function. Cancer Surv. 27, 213-248
30. Llosas, M. D., Batlle, E., Coll, O., Skoudy, A., Fabre, M., and Garcia de Herreros, A. (1996) Evidence for a role of conventional protein kinase C alpha in the control of homotypic contacts and cell scattering of HT-29 human intestinal cells. Biochem. J. 315, 1049-1054
31. Romanova, L.Y., Alexandrov, I. A., Schwab, G., Hilbert, D. M., Mushinski, J. F., and Nordan, R. P. (1996) Mechanism of apoptosis suppression by phorbol ester in IL-6-starved murine plasmacytomas: role of PKC modulation and cell cycle. Biochemistry 335, 9900-9906
32. Manni, A., Buckwalter, E., Etindi, R., Kunselman, S., Rossini, A., Mauger, D., Dabbs, D., and Demers, L. (1996) Induction of a less aggressive breast cancer phenotype by protein kinase C-α and -β overexpression. Cell Growth Differ. 7, 1187-1198
33. Ways, K. D., Kukoly, C. A., deVente, J., Hooker, J. L., Bryant, W. O., Posekany, K. J., Fletcher, D. J., Cook, P. P., and Parker, P. J. (1996) MCF-7 breast cancer cells transfected with protein kinase C-α exhibit altered expression of other protein kinase C isoforms and display a more aggressive phenotype. J. Clin. Invest. 95, 1906-1915
34. Yazaki, T., Ahmad, S., Chahlavi, A., Zylber-Katz, E., Dean, N. M., Rabkin, S. D., Matuza, R. L., and Glazer, R. I. (1996) Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothiate oligodeoxynucleotide. Mol. Pharmacol. 50, 236-242
35. Dean, N., McKay, R., Miraglia, L., Howard, R., Cooper, S., Giddings, J., Nicklin, P., Meister, L., Ziel, R., Geiger, T., Muller, M., and Fabbro, D. (1996) Inhibition of growth of human tumor cell lines in nude mice by an antisense oligonucleotide inhibitor of protein kinase C-α expression. Cancer Res. 56, 3499-3507
36. Goldstein, D. R., Cacace, A. M., and Weinstein, I. B. (1995) Overexpression of protein kinase C β1 in the SW480 colon cancer cell line causes growth suppression. Carcinogenesis 16, 1121-1126
37. Choi, P. M., Tchou-Wong, K.-M., and Weinstein, B. I. (1990) Overexpression of protein kinase C in HT29 colon cancer cells causes growth inhibition and tumor suppression. Mol. Cell. Biol. 10, 4650-4657
38. Borner, C., Ueffing, M., Jaken, S., Parker, P. J., and Weinstein, B. I. (1995) Two closely related isoforms of protein kinase C produce reciprocal effects on the growth of rat fibroblasts. Possible molecular mechanisms. J. Biol. Chem. 270, 78-86
39. Sauma, S., Yan, Z., Ohno, S., and Friedman, E. (1996) Protein kinase Cb1 and protein kinase Cb2 activate p57 mitogen-activated protein kinase and block differentiation in colon carcinom cells. Cell Growth Differ. 7, 587-594
40. Khuri, F. R., Cho, Y., and Talmage, D. A. (1996) Retinoic acid-induced transition from protein kinase Cβ to protein kinase Cα in differentiated F9 cells: correlation with altered regulation of proto-oncogene expression by phorbol esters. Cell Growth Differ. 7, 595-602
41. Inoguchi, T., Battan, R., Handler, E., Sportsman, J. R., Heath, W., and King, G. L. (1992) Preferential elevation of protein kinase C isoform βII and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc. Natl. Acad. Sci. USA 89, 11059-11063
42. Basu, A., and Cline, J. S. (1995) Oncogenic transformation alters cis-platin-induced apoptosis in rat embryo fibroblasts. Int. J. Cancer 63, 597-603
43. Cacace, A. M., Guadagno, S. N., Krauss, R. S., Fabbro, D., and Weinstein, I. B. (1993) The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts. Oncogene 8, 2095-2104
44. Mischak, H., Goodnight, J. A., Kölch, W., Martiny-Baron, G., Schächtele, C., Kazanietz, M. G., Blumberg, P. M., Pierce, J. H., and Mushinski, J. F. (1993) Overexpression of protein kinase C-δ and -ε in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. J. Biol. Chem. 268, 6090-6096
45. Watanabe, T., Ono, Y., Taniyama, Y., Hazama, K., Igarashi, K., Ogita, K., Kikkawa, U., and Nishizuka, Y. (1992) Cell division arrest induced by phorbol ester in CHO cells overexpressing protein kinase-C-δ subspecies. Proc. Natl. Acad. Sci. USA 89, 10159-10163
46. La-Porta, C. A., and Comolli, R. (1995) Over-expression of protein kinase C delta is associated with a delay in preneoplastic lesion development in diethylnitrosamine-induced rat hepatocarcinogenesis. Carcinogenesis 16, 1233-1238
47. Ghayur, T., Hugunin, M., Talanian, R. V., Ratnofsky, S., Quinlan, C., Emoto, Y., Pandey, P., Datta, R., Huang, Y., Kharbanda, S., Allen, H., Kamen, R., Wong, W., and Kufe, D. (1996) Proteolytic activation of protein kinase C δ by an ICE/CED3-like protease induces characteristics of apoptosis. J. Exp. Med. 184, 2399-2404
48. Greif, H., Ben-Chaim, J., Shimon, T., Bechor, E., Eldar, H., and Livneh, E. (1992) The protein kinase G-related PKC-L (eta) gene product is localized in the cell nucleus. Mol. Cell. Biol. 12, 1304-1311
49. Baier, G., Baier-Bitterlich, G., Meller, N., Coggeshall, M. K., Giampa, L., Telford, D., Isakov, N., and Altman, A. (1994) Expression and biochemical characterization of human protein kinase C-θ. Eur. J. Biochem. 225, 195-203
50. Diaz-Meco, M. T., Municio, M. M., Frutos, S., Sanchez, P., Lozano, J., Sanz, L., and Moscat, J. (1966) The product of par-4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinase C. Cell 86, 777-786
51. Lozano, J., Berra, E., Municio, M. M., Diaz-Meco, M. T., Dominguez, I., Sanz, L., and Moscat, J. (1994) Protein kinase C z isoform is critical for κB-dependent promoter activation by sphingomyelinase. J Biol. Chem. 269, 19200-19202
52. Lucas, M., and Sanchez-Margalet, V. (1995) Protein kinase C involvement in apoptosis. Gen. Pharmacol. 5, 881-887
53. Lavin, M. F., Watters, D., and Song, Q. (1996) Role of protein kinases in apoptosis. Experientia 52, 979-994
54. Gescher, A. (1992) Towards selective pharmacological modulation of protein kinase C - opportunities for the development of novel antineoplastic agents. Br. J. Cancer 66, 10-19
55. Bradshaw, D., Hill, C. H. and Wilkinson, S. E. (1993) Therapeutic potential of protein kinase C inibitors. Agents Actions 38, 135-147
56. Basu, A. (1993) The potential of protein kinase C as a target for anticancer treatment. Pharmacol. & Ther. 59, 257-280
57. Dean, N. M., and McKay, R. (1993) Inhibition of protein kinase C-γ expression in mice after systemic administration of phosphorothioate antisense oligodeoxy-nucleotides. Proc. Natl. Acad. Sci. USA 91, 11762-11766
58. Godson, C., Bell, K. S., and Insel, P. A. (1993) Inhibition of expression of protein kinase-C-α by antisense cDNA inhibits phorbol ester-mediated arachidonate release. J. Biol. Chem. 268, 11946-11950
59. Ahmad, S., Safa, A. R., and Glazer, R. I. (1994) Modulation of P-glycoprotein by protein kinase C α in a baculovirus expression system. Biochemistry 33, 10313-10318
60. Balboa, M. A., Firestein, B. L., Godson, C., Bell, K. S., and Insel, P. A. (1994) Protein kinase C-α mediates phospholipase D activation by nucleotides and phorbol ester in Madin-Darby canine kidney cells. J. Biol. Chem. 269, 10511-10526
61. Dean, N. M., McKay, R., Condon, T. P., and Bennett, C. F. (1994) Inhibition of protein kinase C-α expression in human A549 cells by antisense oligonucleotides inhibits induction of intracellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters. J. Biol. Chem. 169, 16416-16424
62. Berra, E., Diaz-Meco M. T., Dominguez, I., Municio, M. M., Sanz, L., Lozano, J., Chapkin, R. S., and Moscat, J. (1993) Protein kinase-C-ζ isoform is critical for mitogenic signal transduction. Cell 74, 555-563
63. Li, W., Yu, J.-C., Shin, D.-Y., and Pierce, J. H. (1995) Characterization of protein kinase C-δ (PKC-δ) ATP binding mutant. An inactive enzyme that competitively inhibits wild type PKC-δ enzymatic activity. J. Biol. Chem. 270, 8311-8318
64. Zimmermann, J., Caravatti, G., Fabbro, D., Mett, H., Müller, M., Regenass, U., and Meyer, T. (1994) Phenylamino-pyrimidines -a new class of highly selective PKC-inhibitors. International Meeting on Growth Control and Therapy of Cancer, abstr. 015, Budapest
65. Ishii, H., Jirousek, M. R., Koya, D., Takagi, C., Xia, P., Clermont, A., Bursell, S.-E., Kern, T. S., Ballas, L. M., Heath, W. F., Stramm, L. E., Feener, E. P., and King., G. L. (1996) Amelioration of vascular dysfunctions in diabetic rats by an oral PKCβ inhibitor. Science 272, 728-731
66. Caravatti, G., Meyer, T., Fredhagen, A., Trinks, U., Mett, H., and Fabbro, D. (1994) Inhibitory activity and selectivity of staurosporine derivatives towards protein kinase C. Bioorg. Med. Chem. Lett. 4, 399-404
67. Hu, H. (1996) Recent discovery and development of selective protein kinase C inhibitors. Drug Discov. Today 1, 438-447
68. Gschwendt, M., Horn, F., Kittstein, W., and Marks, F. (1983) Inhibition of the calcium-and phospholipid-dependent protein kinase activity from mouse brain cytosol by quercetin. Biochem. Biophys. Res. Commun. 117, 444-447
69. Ferriola, P. C., Cody, V., and Middleton, E. (1989) Protein kinase C inhibition by plant flavoids: Kinetic mechanisms and structure-activity relationships. Biochem. Pharmacol. 38, 1617-1624
70. Hidaka, H., Ingaki, M., Kawamoto, S., and Sasaki, Y. (1984) Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide protein kinase and protein kinase C. Biochemistry 23, 5036-5041
71. 2+-dependent protein kinase. Biochem. Biophys. Res. Commun. 135, 397-402
72. Yamada, K., Iwahashi, K., and Kase, H. (1987) K252a, a new inhibitor of protein kinase C, concomitantly inhibits 40K protein phosphorylation and serotonin secretion in phorbol ester-stimulated platelets. Biochem. Biophys. Res. Commun. 144, 35-40
73. Etindi, R. N., and Rillema, J. A. (1987) Effect of kinase C inhibitor, gossypol, on the actions of prolactin in cultured mouse mammary tissues. Biochem. Biophys. Acta 927, 345-349
74. Hannun, Y. A., and Bell, R. M. (1988) Aminoacridines, potent inhibitors of protein kinase C. J. Biol. Chem. 263, 5124-5131
75. Loomis, C. R., and Bell, R. M. (1988) Sangivamycin, a nucleoside analogue, is a potent inhibitor of protein kinase C. J. Biol. Chem. 263, 1682-1692
76. O'Brian, C. A., and Ward, N. E. (1989) ATP-sensitive binding of melittin to the catalytic domain of protein kinase C. Biochem. Pharmacol. 36, 355-359
77. Meyer, T., Regenass, U., Fabbro, D., Alteri, E., Rösel, J., Müller, M., Caravatti, G., and Matter, A. (1989) A derivative of staurosporine (CGP 41251) shows selectivity for protein kinase C inhibition and in vitro anti-proliferative activity. Int. J. Cancer 43, 851-856
78. Wise, B. C., and Kuo, J. F. (1983) Modes of inhibition by acylcarnitines adriamycin and trifluoperazine of cardiac phospholipid-sensitive calcium-dependent protein kinase. Biochem. Pharmacol. 32, 1259-1265
79. Hannun, Y. A., Foglesong, R. J., and Bell. R. M. (1989) The adriamycin-iron(III) complex is a potent inhibitor of protein kinase C. J. Biol. Chem. 264, 9960-9966
80. Herbert, J. M., Augereau, J. M., Gleye, J., and Maffrand, J. P. (1990) Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 172, 993-999
81. Mahoney, C. W., Azzi, A., and Huang, K. P. (1990) Effects of suramin, an anti-human immunodeficiency virus reverse transcriptase agent, on protein kinase C. J. Biol. Chem. 265, 5424-5428
82. Rotenberg, S. A., Smiley, S., Ueffing, M., Krauss, R. S., Chen, L. B., and Weinstein, I. B. (1990) Inhibition of rodent protein kinase C by the anticarcinoma agent dequalinium. Cancer Res. 50, 677-685
83. Dieter, P., and Fitzke, E. (1991) RO 31-8220 and RO 31-7549 show improved selectivity for protein kinase C over staurosporine in macrophages. Biochem. Biophys. Res. Commun. 181, 396-401
84. Birchall, A. M., Bishop, J., Bradshaw, D., Cline, A., Coffey, J., Elliot, L. H., Gibson, V. M., Greenham, A., Hallam, T. J., Harris, W., Hill, C. H., Hutchings, A., Lamont, A. G., Lawton, G., Lewis, E. J., Maw, A., Nixon, J. S., Pole, D., Wadsworth, J., and Wilkinson, S. E. (1994) Ro 32-0432, a selective and orally active inhibitor of protein kinase C prevents T-cell activation. J. Pharmacol Exp. Ther. 268, 922-999
85. Toullec, D., Pianetti, P., Coste, H., Bellevergue, P., Grand-Perret, T., Ajakane, M., Baudet, V., Boissing, P., Boursier, E., Loriolle, F., Duhamel, L., Charon, D., and Kirilovsky, J. (1991) The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266, 15771-15781
86. Martiny-Baron, G., Kazanietz, M. G., Mischak, H., Blumberg, P. M, Kochs, G., Hug, H., Marme, D., and Schächtele, C. (1993) Selective inhibition of protein kinase G isozymes by the indolcarbazole Go 6976. J. Biol. Chem. 268, 9194-9197
87. Seynaeve, C. M., Kazanietz, M. G., Blumberg, P. M., Sausville, A. E., and Worland, P. J. (1994) Differential inhibition of protein kinase C isozymes by UCN-01, a staurosporine analogue. Mol. Pharmacol. 45, 1207-1214
88. Gschwendt, M., Muller, H. J., Kielbassa, K., Zang, R., Kittstein, W., Rincke, G., and Marks, F. (1994) Rottlerin, a novel protein kinase inhibitor. Biochem. Biophys. Res. Commun. 199, 93-98
89. Chan, J.A., Freyer, A. J., Carte, B. K., Hemling, M. E., Hofmann, G. A., Mattern, M. R., Mentzer, M. A., and Westley, J. W. (1994) Protein kinase C inhibitors: novel spirosesquiterpene aldehydes from a marine sponge Aka (Sidophonodicton) coralliphagum. J. Nat. Prod. 4877, 1543-1548
90. Zimmermann, J., Caravatti, G., Mett, H., Meyer, T., Müller, M., Lydon, N. B., and Fabbro, D. (1996) Phenylamino-pyrimidine (PAP) derivatives: a new class of potent and selective inhibitors of protein kinase C (PKC). Arch. Pharm. Med. Chem. 329, 371-376
91. Birch, K. A., Heath, W. F., Hermeling, R. N., Johnston, C. M., Stramm, L., Dell, S., Smith, C., Williamson, J. R., and Reifel-Miller, A. (1996) LY290181, an inhibitor of diabetes-induced vascular dysfunction, blocks protein kinase C-stimulated transcriptional activation through inhibition of transcription factor binding to a phorbol response element. Diabetes 45, 642-650
92. Blumberg, P. M. (1991) Complexities of the protein kinase C pathway. Mol. Carcinog. 4, 339-344
93. Miyake, R., Tanaka, Y., Tsuda, T., Kaibuchi, K., Kikkawa, U., and Nishizuka, Y. (1984) Activation of protein kinase C by nonphorbol tumor promoter, mezerein. Biochem. Biophys. Res. Commun. 121, 649-656
94. Fujiki, H., Tanaka, Y., Niyake, R., Kikkawa, U., Nishizuka, Y., and Sugimura, T. (1984) Activation of calcium-activated, phospholipid-dependent protein kinase (protein kinase C) by new classes of tumor promoters: telcocidin and debromoaplysia-toxin. Biophys. Res. Commun. 120, 339-343
95. Arcoleo, J. P., and Weinstein, I. B. (1985) Activation of protein kinase C by tumor promoting phorbol esters, teleocidin and aplysiatoxin in the absence of added calcium. Carcinogenesis 6, 213-217
96. Mori, T., Takai, Y., Minakuchi, R., Yu., B., and Nishizuka, Y. (1983) Inhibitory action of chlorpromazine, dibucain and other phospholipid-interacting drugs on protein kinase C. J. Biol. Chem. 255, 8378-8380
97. Su, H. D., Mazzei, G. J., Vogler, W. R., and Kuo, J. F. (1985) Effect of tamoxifen, a non-steroidal antiestrogen, on phospholipid/calcium dependent protein kinase and phosphorylation of its endogenous substrate proteins from the rat brain and ovary. Biochem. Pharmacol. 34, 3649-3653
98. 2+-dependent protein kinase (protein kinase C) system from human leukemic cells. Cancer Res. 46, 3684-3687
99. Momoi, T. (1986) Activation of protein kinase C by ganglioside GM3 in the presence of calcium and 12-O-tetradecanoylphorbol-13-acetate. Biochem. Biophys. Res. Commun. 138, 854-871
100. Vaccarino, F., Guidotti, A., and Costa, E. (1987) Ganglioside inhibition of glutamate-mediated protein kinase C translocation in primary cultures of cerebellar neurons. Proc. Natl. Acad. Sci. USA 84, 8707-8711
101. Hannun, Y. A, Loomis, C. R., Merrill, A. H.,Jr., and Bell, R. M. (1986) Sphingosine inhibition of protein kinase C activity and phorbol dibutyrate binding in vitro and in human platelets. J. Biol. Chem. 261, 12606-12613
102. Endo, K., Igarashi, Y., Nisar, M., Zhou, Q., and Hakomori, S. (1991) Cell membrane signalling as target in cancer therapy: inhibitory effect of N,N-dimethyl and N,N,N-trimethyl sphingosine derivaties on in vitro and in vivo growth of human tumor cells in nude mice. Cancer Res. 61, 1613-1618
103. Moruzzi, M., Barbiroli, B., Monti, M. G., Tadolini, B., Hakim, G., and Mezzeti, G. (1987) Inhibitory action of polyamines on protein kinase C association to membranes. Biochem. J. 247, 175-180
104. Nakadate, T., and Blumberg, P. M. (1987) Modulation by palmitoylcarnitine of protein kinase C activation. Cancer Res. 47, 6537-6542
105. Aizu, E., Yamamoto, S., Nakadate, T., Kiyoto, I., and Kato, R. (1988) Palmitoylcarnitine reverses 12-O-tetradecanoylphorbol-13-acetate-induced refractory state for the TPA-cansed ornithine decarboxylase induction in mouse epidermis. Carcinogenesis 9, 309-313
106. O'Brian, C., and Weinstein, B. I. (1987) In vitro inhibition of rat brain protein kinase C by rhodamine 6G. Biochem. Pharmacol. 36, 1231-1235
107. Markovac, J., and Goldstein, G. W. (1988) Picomolar concentrations of lead stimulate brain protein kinase C. Nature (London) 334, 71-73
108. Kikkawa, U., Ogita, K., Shearman, M. S., Ase, K., Sekiguchi, K., Naor, Z., Kishimoto, A., Nishizuka, Y., Saito, N., Tanaka, C., Ono, Y., Fujii, T., and Igarashi, K. (1988) The family of protein kinase C: its molecular heterogeneity and differential expression. Cold Spring Harbour Symp. Quant. Biol. III, 97-102
109. Müller, G., Ayoub, M., Storz, P., Rennecke, J., Fabbro, D., and Pfizenmaier, K. (1995) PKC ζ is a molecular switch in signal transduction of TNF-α, bifunctionally regulated by ceramide and arachidonic acid. EMBO J. 14, 1961-1969
110. Silver, P. J., Connell, M. J., Dillon, DK. M., Cumiskey, W. R., Volberg, W. A., and Ezrin, A. M. (1989) Inhibition of calmodulin and protein kinase C by amiodarone and other class III antiarrhythmic agents. Cardiovasc. Drugs Ther. 3, 675-682
111. Kobayashi, E., Nakano, H., Morimoto, M., and Tamaoki, T. (1989) Calphostin C (UCN-1028C), a novel microbial compound is a highly potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 159, 548-553
112. Tamaoki, T., Takahashi, I., Kobayashi, E., Nakano, H., Akinaga, S., and Suzuki, K. (1990) Calphostin (UCN1028) and calphostin related compounds, a new class of specific and potent inhibitors of protein kinase C. Adv. Second Messeng Phosphoprotein Res. 24, 497-501
113. Hofmann, J., Überall, F., Posch, L., Maly, K., Herrmann, D. B. J., and Grunicke H. (1989) Synergistic enhancement of the anti-proliferative activity of cis-diammine-dichloroplatinum(II) by the new ether lipid analogue BM 41 440, an inhibitor of protein kinase C. Lipids 24, 312-317
114. Überall, F., Oberhuber, H., Maly, K., Zaknun, J., Demuth, L., and Grunicke, H. (1991) Hexadecylphosphocholine inhibits inositol phosphate formation and protein kinase C activity. Cancer Res. 51, 807-812
115. Brachwitz, H. and Vollgraf, C. (1995) Analogs of alkyllysophospholipids: chemistry, effects on the molecular level and their consequences for normal and malignant cells. Pharmacol. Ther. 66, 39-82
116. Froscio, M., Murray, A. W., and Hurst, N. P. (1989) Inhibition of protein kinase C activity by the antirheumatic drug auranofin. Biochem. Pharmacol. 38, 2087-2089
117. Überall, F., Maly, K., Egle, A., Doppler, W., Hofmann J. and Grunicke, H. (1991) Inhibition of cell proliferation, protein kinase C and phorbol ester-induced fos expression by the dihydropyridine derivative B859-35. Cancer Res. 51, 5821-5825
118. Lester, D. S., and Baumann, D. (1991) Action of organic solvents on protein kinase C. Eur. J. Pharmacol. 206, 301-308
119. Sullivan, J. P., Connor, J. R., Shearer, B. G., and Burch, R. M. (1991) 2,6-Diamino-N-([1-oxotridecyl)-2-piperidinyl] methyl) hexanamide (NPC15437): a selective inhibitor of protein kinase C. Agents Actions 34, 142-144
120. Boscoboinik, D., Szewczyk, A., Hensey, C., and Azzi, A. (1991) Inhibition of cell proliferation by alpha-tocopherol. Role of protein kinase C. J. Biol. Chem. 266, 6188-6194
121. Robinson, P. J. ( 1992) Potencies of protein kinase C inhibitors are dependent on the activators used to stimulate the enzyme. Biochem. Pharmacol. 44, 1325-1334
122. Ahmed, S., Lee, J., Kozma, R., Best, A., Monfries, C., and Lim, L. (1993) A novel functional target for tumor promoting phorbol esters and lysophosphatidic acid. The p21rac-GTPase activating protein n-chimaerin. J. Biol. Chem. 268, 10709-10712
123. Limatola, C., Schaap, D., Moolenaar, W. H., and van Blitterswijk, W. J. (1994) Phosphatidic acid activation of protein kinase C-ζ overexpressed in COS cells: comparison with other protein kinase C isotypes and other acidic lipids. Biochem. J. 304, 1001-1008
124. Ikuta, T., Chida, K., Tajima, O., Matsuura, Y., Iwamori, M., Ueda, Y., Mizuno, K., Ohno, S., and Kuroki, T. (1994) Cholesterol sulfate, a novel activator for the isoform of protein kinase C. Cell Growth Differ. 5, 943-947
125. Singh, S. S., Chauhan, A., Brockerhoff, H., and Chauhan, V. P. (1994) Interaction of protein kinase C and phosphoinositides: regulation by polyamines. Cell. Signalling 6, 345-353
126. Yeung, J. M., Wang, H. Y., and Prelusky, D. B. (1996) Fumonisin B-1 induces protein kinase C translocation via direct interaction with diacylglycerol binding site. Toxicol. Appl. Pharmacol. 141, 178-184
127. + transport in A6 cells. J. Biol. Chem. 271, 32468-32473
128. Marte, B., Meyer, T., Stabel, S., Standke, G. J., Jaken, S., Fabbro, D., and Hynes, N. E. (1994) Protein kinase C and mammary cell differentiation: involvement of protein kinase C alpha in the induction of beta-casein expression. Cell Growth Differ. 5, 239-247
129. Schwartz, G. K., Redwood, M. S., Ohnuma, T., Holland, J. F., Droller, M. J., and Liu, B. C.-S. (1990) Inhibition of invasion of invasive human bladder carcinoma cells by protein kinase C inhibitor staurosporine. J. Natl. Cancel Inst. 82, 1753-1756
130. O'Brian, C. A., and Ward, N. (1990) Staurosporine: a prototype of a novel class of inhibitors of tumor cell invasion? [Editorial] J. Natl. Cancer Inst. 82, 1734-1735
131. Mapelli, E., Banfi, P., Sala, E., Sensi, M., Supino, R., Zunino, F., and Gambetta, R. A. (1994) Effect of protein kinase C inhibitors on invasiveness of human melanoma clones expressing different levels of protein kinase C isoenzymes. Int. J. Cancer 57, 281-286
132. Jacobson, P. B., Kuchera, S. L., Metz, A., Schächtele, C., Imre, K., and Schrier, D. J. (1995) Anti-inflammatory properties of Go 6850: a selective inhibitor of protein kinase C. J. Pharmacol. Exp. Therap. 275, 995-1002
133. Gekeler, V., Boer, R., Ise, W., Sanders, K. H., Schächtele, C., and Beck. J. (1995) The specific bisindolylmaleimide PKC-inhibitor GF 109203X efficiently modulates MRP-associated multiple drug resistance. Biochem. Biophys. Res. Commun. 206, 119-126
134. Akinaga, S., Gomi, K, Morimoto, M., Tamaoki, T., and Okabe, M. (1991) Antitumor activity of UCN-01, a selective inhibitor of protein kinase C, in murine and tumor models. Cancer Res. 51, 4888-4892
135. Prendiville, J., Crowther, D., Thatcher, N., Woll, P. J., Fox, B. W., McGown, A., Testa, N., Stern, P., McDermott, R., Potter, M., and Pettit, G. R. (1993) A phase I study of intravenous bryostatin 1 in patients with advanced cancer. Br. J. Cancer 68, 418-424
136. Szallasi, Z., Du, L., Levine, R., Lewin, N. E., Nguyen, P. N., Williams, M. D., Pettit, G. R., and Blumberg, P. M. (1996) The bryostatins inhibit growth of B16/F10 melanoma cells in vitro through a protein kinase C-independent mechanism: dissociation of activities using 26-epi-bryostatin 1. Cancer Res. 56, 2105-2111
137. Ukena, D., Boewer, C., Oldenkott, B., Rathgeb, F., Wurst, W., Zech, K., and Sybrecht, G. W. (1995) Tolerance, safety, and kinetics of the new antineoptastic compound dexniguldipine-HCl after oral administration: a phase I dose-escalation trial. Cancer Chemother. Pharmacol. 36, 160-164
138. Hofmann, J., Überall, F., Egle, A., and Grunicke, H. (1991) B-859-35, a new drug with antitumor activity reverses multidrug resistance. Int. J. Cancer 47, 870-874
139. Hofmann, J., Wolf, A., Spitaler, M., Böck, G., Drach, J., Ludescher, C., and Grunicke, H. (1992) Reversal of multidrug resistance by B859-35, a metabolite of B859-35, niguldipine, verapamil and nitrendipine. J. Cancer Res. Clin. Oncol. 118, 361-366
140. Czendlik, C., and Graf, P. (1996) Safety, tolerability and pharmacokinetics of CGP 41251, a protein kinase C inhibitor (phase I study). Ann. Oncol. 7, Suppl. 1, 264
141. Utz, I., Hofer, S., Regenass, U., Hilbe, W., Thaler, J., Grunicke, H., and Hofmann, J. (1994) The protein kinase C inhibitor CGP 41251, a staurosporine derivative with antitumor activity, reverses multidrug resistance. Int. J. Cancer 57, 104-110
142. Hofmann, J., Gekeler, V., Ise, W., Noller, A., Mitterdorfer, J., Hofer, S., Utz, I., Gotwald, M., Boer, R., Glossmann, H., and Grunicke, H. (1995) Mechanism of action of dexniguldipine-HCl (B8509-035), a new potent modulator of multidrug resistance. Biochem. Pharmacol. 49, 603-609
143. Smith, C. D., and Zilfou, J. T. (1995) Circumvention of P-glycoprotein-mediated multiple drug resistance by phosphorylation modulators is independent of protein kinases. J. Biol. Chem. 270, 28145-28152
144. Goodfellow, H. R., Sardini, A., Ruetz, S., Callaghan, R., Gros, P., Mcnaughton, P. A., and Higgins, C. F. (1996) Protein kinase C-mediated phosphorylation does not regulate drug transport by the human multidrug resistance P-glycoprotein. J. Biol. Chem. 271, 13668-13674
145. Budworth, J., Davies, R., Malkhandi, J., Gant, T. W., Ferry, D. R., and Gescher, A. (1996) Comparison of staurosporine and four analogues: their effects on growth, rhodamine 123 retention and binding to P-glycoprotein in multidnig-resistant MCF-7/Adr cells. Br. J. Cancer 73, 1063-1068
146. Gekeler, V., Boer, R., Überall, F., Ise, W., Schubert, C., Utz, I., Hofmann, J., Sanders, K. H., Schächtele, C., Klemm, K., and Grunicke, H. (1996) Effects of the selective bisindolylmaleimide protein kinase O inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance. Br. J. Cancer 74, 897-905
147. Winkelmann, M., Ebeling, K., Strohmeyer, G., Hottenrott, G., Mechl, Z., Berges, W., Scholten, T., Westerhausen, M., Schlimok, G., and Sterz, R. (1992) Treatment results of the thioether lipid ilmofosine in patients with malignant tumours. J. Cancer Res. Clin. Oncol. 118, 405-407
148. Hofmann, J., O'Connor, P. M., Jackman, J., Schubert, C., Überall, F., Kohn, K. W., and Grunicke, H. (1994) The protein kinase C inhibitor ilmofosine (BM 41 440) arrests ceils in G2 phase and suppresses cdc2 kinase activation through a mechanism different from that of DNA damaging agents. Biochem. Biophys. Res. Commun. 199, 937-943
149. Herrmann, D. B. J., Pahlke, W., Opitz, H.-G., and Bicker, U. (1990) In vivo antitumor activity of ilmofosine. Cancer Treat. Rev. 17, 247-252
150. Hilgard, P., Klenner, T., Stekar, J., and Unger, C. (1993) Alkylphosphocholines: a new class of membrane-active anticancer agents. Cancer Chemother. Pharmacol. 32, 90-95
151. Courage, C., Budworth, J., and Gescher, A. (1995) Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localisation. Br. J. Cancer 71, 697-704
152. Hofmann, J., Doppler, W., Jakob, A., Posch, L., Überall, F., and Grunicke, H. (1988) Enhancement of the antiproliferative effect of cis-diamminedichloroplatinum(II) and nitrogen mustard by inhibitors of protein kinase C. Int. J. Cancer 42, 382-388
153. Hofmann, J., Fiebig, H. H., Winterhalter, B. R., Berger, D. P., and Grunicke, H. (1990) Enhancement of the antiproliferative activity of cis-diamminedichloroplatinum(II) by quercetin. Int. J. Cancer 45, 536-539
154. Fyfe, D., Ferry, D. R., Smith, A., de Takats, P., Baker, J., and Kerr, D. J. (1996) Phase I clinical trial of the tyrosine kinase inhibitor quercetin combined with carboplatin in advanced cancer. Ann. Oncol. 7, Suppl. 1, 263
155. Adams, L. M., Cofield, D. J. Seldin, J. C., Kitchen, P. A., Harrison, S. D., and Darges. J. W. (1993) Effect of the protein kinase C (PKC) inhibitor SPC-100270 on drug accumulation and cytotoxicity in drug resistant and sensitive tumor cells in vitro. Proc. Am. Assoc. Cancer Res. 34, 2447
156. Adams, L. M., Dykes, D., Harrison, S. D., Saleh, J., and Saah, L. (1993) Combined effect of the chemopotentiator SPC-100270, a protein kinase C (PKC)
157. Schwartz, G. K., Haimovitz-Friedman, A., Dhupar, S. K., Ehleiter, D., Maslak, P., Lai, L., Loganzo, F., Jr., Kelsen, D. P., Fuks, Z., and Albino, A. P. (1995) Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cells. J. Natl. Cancer Inst. 87, 1394-1399
158. Pears, C., Schaap, D., and Parker, P. J. (1991) The regulatory domain of protein kinase C-ε restricts the catalytic domain specificity. Biochem. J. 276, 257-260
159. Ohno, S., Konno, Y., Akita, Y., Yano, A., and Suzuki, K. (1990) A point mutation at the putative ATP-binding site of protein kinase C alpha abolishes the kinase activity and renders it down-regulation-insensitive. A molecular link between autophosphorylation and down-regulation. J. Biol. Chem. 265, 6296-6300
160. Finkenzeller, G., Marine, D., and Hug, H. (1990) Sequence of human protein kinase C alpha. Nucleic Acids Res. 18, 2183
161. Kochs, G., Hummel, R., Meyer, D., Hug, Hubert, Marme, D., and Sarre, T. F. (1993) Activation and substrate specificity of the human protein kinase Cα and ζ isoenzymes. Eur. J. Biochem. 216, 597-606
162. Kubo, K., Ohno, S., and Suzuki, K. (1987) Primary structures of human protein kinase C beta I and beta II differ only in their C-terminal sequences. FEBS Lett. 223, 138-142.
163. Coussens, L., Parker, P. J., Rhee, L., Yang-Feng, T. L., Chen, E., Waterfield, M. D., Francke, U., and Ullrich, A. (1986) Multiple distinct forms of protein kinase C suggest diversity in cellular signaling pathways. Science 233, 859-866
164. Basta, P., Strickland, M. B., Holmes, W., Loomis, C. R., Ballas, L. M., and Burns, D. J. (1992) Sequence and expression of protein kinase C-epsilon. Biochem. Biophys. Acta 1132, 154-160
165. Bacher, N., Zisman, Y., Berent, E., and Livneh, E. (1991) Isolation and characterization of PKC-L, a new member of the protein kinase C-related gene family specifically expressed in lung, skin, and heart. Mol. Cell. Biol. 11, 126-133
166. Aris, J. P., Basta, P. V., Holmes, W. D., Ballas, L. M., Moomaw, C., Rankl, N. B., Blobel, G., Loomis, C. R., and Burns, D. J. (1993) Molecular and biochemical characterization of a recombinant human PKC-delta family member. Biochem. Biophys. Acta 1174, 171-181
167. Baier, G., Telford, D., Giampa, L., Coggeshall, K. M., Baier-Bitterlich, G., Isakov, N., and Altman, A. (1993) Molecular cloning and characterization of PKC theta, a novel member of the protein kinase C (PKC) gene family expressed predominantly in hematopoietic cells. J. Biol. Chem. 258, 4997-5004
168. Selbie, L. A., Schmitz-Pfeiffer, C., Sheng, Y., and Biden, T. J. (1993) Molecular cloning and characterization of PKC iota, an atypical isoform of protein kinase C derived from insulin-secreting cells. J. Biol. Chem. 268, 24296-24302
169. Kemp, B. E., and Pearson, R. B. (1990) Protein kinase recognition sequence motifs. Trends Biochem. Sci. 15, 342-346
170. Taylor, S. S., Buechler, J. A., and Yonemoto, W. (1990) cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. Annu. Rev. Biochem. 59, 971-1005
171. Levitzki, A. (1996) Targeting signal transduction for disease therapy. Curr. Opin. Cell Biol. 8, 241-244
172. Levitzki, A., and Gazit, A. (1995) Tyrosine kinase inhibition: an approach to drug development. Science 267, 1782-1788
173. Graff, J. M., Rajan, R. R., Randall, R. R., Nairn, A. C., and Blackshear, P. J. (1991) Protein kinase C substrate and inhibtor characteristics of peptides derived from the myristoylated alanine-rich C kinase substrate (MARCKS) protein phosphorylation site domain. J. Biol. Chem. 266, 14390-14398
174. Amess, B., Manjarrez-Hernandez, A. H., Howell, S. A., Learmonth, M., and Aitken, A. (1992) Multisite phosphorylation of the 80 kDa (MARCKS) protein kinase C substrate in C3H/ 10T1/2 fibroblasts. FEBS Lett. 297, 285-291
175. Li, J., and Aderem, A. (1992) MacMARCKS, a novel member of the MARCKS family of protein kinase C substrates. Cell 70, 791-801
176. Chakravarthy, B. R., Bussey, A., Whitfield, J. F., Sikorsky, M., Williams, R. E., and Durkin, J. P. (1991) The direct measurement of protein kinase C (PKC) activity in isolated membranes using a selective peptide substrate. Anal. Biochem. 196, 144-150
177. Chen, S-J., Klann, E., Gower, M. C., Powell, C. M., Sessoms, S. J., and Sweatt, D. J. (1993) Studies with synthetic peptide substrates derived from neuronal protein neurogranin reveal structural determinants of potency and selectivity for protein kinase C. Biochemistry 32, 1032-1039
178. Gonzalez, A., Klann, E., Sessoms, S. J., and Chen, S.-J. (1993) Use of the synthetic peptide neurogranin(28-43) as a selective protein kinase C substrate in assays of tissue homogenates. Anal. Biochem. 215, 184-189
179. Apel, E. D., Byford, M. F., Au, D., Walsh, K. A., and Storm, D. R. (1990) Identification of protein kinase C phosphorylation site in neuromodulin. Biochemistry 29, 2330-2335
180. House, C., Wettenhall, R. E. H., and Kemp, B. E. (1987) Influence of basic residues on the substrate specificity of protein kinase C. J. Biol. Chem. 262, 772-777
181. 2+/phosholipid-dependent protein kinase (protein kinase C) and cAMP-dependent protein kinase as evidenced by synthetic peptide substrates. FEBS Lett. 184, 72-77
182. Woodgett, J. R., Gould, K. L., and Hunter, T. (1986) Substrate specificity of protein kinase C. Eur. J. Biochem. 161, 177-184
183. Ward, N. E., and O'Brian, C. A. (1993) Inhibition of protein kinase C by N-myristoylated peptide substrate analogs. Biochemistry 32, 11903-11909
184. Heasley, L. E., and Johnson, G. L. (1989) Regulation of protein kinase C by nerve growth factor, epidermal growth factor, and phorbol esters in PC12 pheochromocytoma cells. J. Biol. Chem. 264, 8646-8652
185. Hunter, T., Ling, N., and Cooper, J. A. (1984) Protein kinase C phosphorylation of the EGF receptor at a threonine residue close to the cytoplasmatic face of the plasma membrane. Nature (London) 311, 480-483
186. 2+ phospholipid-dependent and independent phosphorylation of synthetic peptide substrates by protein kinase C. Eur. J. Biochem. 163, 481-487
187. Kishimoto, A., Nishiyma, K., Nakanishi, H., Uratsuji, Y., Nomura, H., Takeyama, Y., and Nishizuka, Y. (1995) Studies on the phosphorylation of myelin basic protein by protein kinase C and adenosine 3′:5′monophosphate-dependent protein kinase. J. Biol. Chem. 260, 12492-12499
188. Yasuda, I., Kishimoto, A., Tanaka, S., Tominaga, M., Sakurai, A., and Nishizuka, Y. (1990) A synthetic peptide substrate for selective assay of protein kinase C. Biochem. Biophys. Res. Commun. 166, 1220-1227
189. 2+-dependent protein kinase as probed with synthetic peptide fragments of the bovine myelin basic protein. J. Biol. Chem. 260, 11503-11507
190. 2+/ calmodulin-dependent protein kinase II. Eur. J. Biochem. 192, 263-273
191. Chan, J. K.-F., Stoner, G. L., Hashim, G. A., and Huang, K.-P. (1986) Substrate specificity of rat brain calcium-activated and phospholipid-dependent protein kinase. Biochem. Biophys. Res. Commun. 134, 1358-1364
192. Kondo, H., Baba, Y., Takaki, K., Kondo, K., and Kagamiyma, H. (1987) Phosphorylation by protein kinase C of a synthetic heptapeptide bearing a lysine residue on the C terminal side of serine. Biochem. Biophys. Res. Commun. 142, 155-161
193. 2+ or a phorbol ester tumor promoter. Biochem. Biophys. Res. Commun. 124, 296-302
194. Nishizuka, Y., Takai, Y., Kishimoto, A., Hashimoto, E., Inoue, M., Yamamoto, M., Criss, W. E., and Kuroda, Y. (1979) A role of calcium in the activation of a new protein kinase system. Adv. Cyclic Nucleotide Res. 9, 209-220
195. Ramachandran, C., Yau, P., Bradbury, M. E., Shyamala, G., Yasuda, H., and Walsh, D. A. (1984) Phosphorylation of high-mobility-group proteins by the calcium-phospholipid-dependent protein kinase and the cyclic AMP-dependent kinase. J. Biol. Chem. 259, 13495-13503
196. House, C., and Kemp, B. E. (1987) Protein kinase C contains a pseudosubstrate prototype in its regulatory domain. Science238, 1726-1728
197. Craig, K. L., and Harley, C. B. (1996) Phosphorylation of human pleckstrin on ser-113 and ser-117 by protein kinase C. Biochem. J. 314, 937-942
198. Blake, A. D., Mumford, R. A., Strout, V. H., Slater, E. E., and Strader, C. D. (1987) Synthetic segments of the mammalian βAR are preferentially recognized by cAMP-dependent protein kinase and protein kinase C. Biochem. Biophys. Res. Commun. 147, 168-173
199. Noland, T. A., Jr., Raynor, R. L., and Kuo, J. F. (1989) Identification of sites phosphorylated in bovine cardiac troponin I and troponin T by protein kinase C and comparative substrate activity of synthetic peptides containing the phosphorylation sites. J. Biol. Chem. 264, 20778-20785
200. Gould, K. L., Woodgett, J. R., Cooper, J. A., Buss, J. E., Shalloway, D., and Hunter, T. (1985) Protein kinase C phosphorylates pp60src at a novel site. Cell 42, 849-857
201. Kwon, Y.-G., Mendelow, M., and Lawrence, D. S. (1994) The active site substrate specificity of protein kinase C. J. Biol. Chem. 269, 4839-4844
202. Hvalby, O, Hemmings, H. C., Jr., Paulsen, O., Czernik, A. J., Nairn, A. C., Godfraind, J.-M., Jensen, V., Raastad, M., Storm, J. F., Andersen, P., and Greengard, P. (1994) Specificity of protein kinase inhibitor peptides and induction of long-term potentiation. Proc. Natl. Acad. Sci. USA 91, 4761-4765
203. Takenaka, I., Morin, F., Seizinger, B. R., and Kley, N. (1995) Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphatases. J. Biol. Chem. 270, 5405-5411
204. Chambers, T. C., Germann, U. A., Gottesman, M. M., Pastan, I., Kuo, J. F., and Ambudkar, S. V. (1995) Bacterial expression of the linker region of human MDR1-P-glycoprotein and mutational analysis of phosphorylation sites. Biochemistry 34, 14156-14162
205. Wells, N. J., Fry, A. M., Guano, F., Norbury, C., and Hickson, I. D. (1995) Cell cycle phase-specific phosphorylation of human topoisomerase II α. Evidence of a role for protein kinase C. J. Biol. Chem. 47, 28357-28363
206. Araujo, J., Danziger, N., Cordier, J., Glowinski, J., and Chneiweiss, H. (1993) Characterization of PEA-15, a major substrate for protein kinase C in astrocytes. J. Biol. Chem. 268, 5911-5920
207. Feinstein, D. L., Weinmaster, G. A., and Milner, R. J. (1992) Isolation of cDNA clones encoding rat glial acidic protein: expression in astrocytes and Schwann cells. J. Neurosci. Res. 32, 1-14
208. Gandino, L., Longati, P., Medico, E., Prat, M., and Comgoglio, P. M. (1994) Phosphorylation of serine 985 negatively regulates the hepatocate growth factor receptor kinase. J. Biol. Chem. 269, 1815-1820
209. +-ATPase affects its conformational equilibrium. Proc. Natl. Acad. Sci. USA 93, 9132-9137
210. Gould, K. L., Woodgett, J. R., Isacke, C. M., and Hunter T. (1986) The protein-tyrosine kinase substrate p36 is also a substrate for protein kinase C in vitro and in vivo. Mol. Cell. Biol. 6, 2738-2744
211. Johnsson, N., Nguyen-Van, P. N., Söling, H. D., and Weber, K. (1986) Functionally distinct serine phosphorylation sites of p36, the cellular substrate of retroviral protein kinase; differential inhibition of reassociation with p11. EMBO J. 5, 3455-3460
212. Jost, M., and Gerke, V. (1996) Mapping of a regulatory important site for protein kinase C phosphorylation in the N-terminal domain of annexin II. Biochem. Biophys. Acta 1313, 283-289
213. Graff, J. M., Stumpo, D. J., and Blackshear, P. J. (1989) Characterization of the phosphorylation sites in the chicken and bovine myristoylated alanine-rich C kinase substrate protein, a prominent celluar substrate for protein kinase C. J. Biol. Chem. 264, 11912-11919
214. Harlan, D. M., Graff, J. M., Stumpo, D. J., Eddy, R. L., Jr., Shows, T. B., Boyle, J. M., and Blackshear, P. J. (1991) The human myristoylated alanine-rich kinase C substrate (MARCKS) gene (MACS). Analysis of its gene product, promoter, and chromosomal localization. J. Biol. Chem. 266, 14399-14405
215. Herget, T., Oehrlein, S. A., Pappin, D. J. C., Rozengurt, E., and Parker, P. J. (1995) The myristoylated alanine-rich C-kinase substrate (MARCKS) is sequentially phosphorylated by conventional, novel and atypical isotypes of protein kinase C. Eur. J. Biochem. 233, 448-457
216. Huang, K.-P., Huang, F. L., and Chen, H.-C. (1993) Characterization of a 7.5-kDa protein kinase C substrate (RC3 protein, neurogranin) from rat brain. Arch. Biochem. Biophys. 305, 570-580
217. Kennelly, P. J., and Krebs, E. G. (1991) Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases. J. Biol. Chem. 266, 15555-15558
218. 2+ dependent protein kinase from heart. J. Biol. Chem. 257, 8489-8495
219. Hocevar, B. A., Burns, D. J., and Fields, A. P. (1993) Identification of protein kinase C (PKC) sites on human lamin B. J. Biol. Chem. 268, 7545-7552
220. Dekker, L. V., McIntyre, P., and Parker, P. J. (1993) Altered substrate selectivity of PKC-η pseudosubstrate site mutants. FEBS Lett. 329, 129-133
221. Olivier, A. R., and Parker, P. J. (1991) Expression and characterization of protein kinase-C-δ. Eur. J. Biochem. 200, 805-810
222. Dekker, L. V., Parker, P., and McIntyre, P. (1992) Biochemical properties of rat protein kinase C-η expressed in COS cells. FEBS Lett. 312, 195-199
223. Schaap, D., and Parker, P. J. (1990) Expression, purification, and characterization of protein kinase C-ε. J. Biol. Chem. 265, 7301-7307
224. Ono, Y., Fujii, T., Ogita, K., Kikkawa, U., Igarashi, K., and Nishizuka, Y. (1989) PKC-ζ subspecies from rat brain: its structure, expression, and properties. Proc. Natl. Acad. Sci. USA 86, 3099-3103
225. Flindt, A., Paladini, R. D., and Koshland. D. E., Jr. (1990) Autophosphorylation of protein kinase C at three separated regions of its primary sequence. Science 249, 408-410
226. Nishikawa, K., Toker, A., Johannes, F.-J., Songyang, Z., and Cantley, L. C. (1997) Determination of the specific substrate sequence motifs of protein kinase C isozymes. J. Biol. Chem. 272, 952-960
227. Marais, R. M., and Parker, P. J. (1989) Purification and characterisation of bovine brain protein kinase C isotypes α, β and γ. Eur. J. Biochem. 182, 129-137
228. Marais, R. M., Nguyen, O., Woodgett, J. R., and Parker, P. J. (1990). Studies on the primary sequence requirements for PKC-α, -β1 and -γ peptide substrates. FEBS Lett. 277, 151-155
229. Kielbassa, K., Müller, H.-J., Meyer, H. E., Marks, F., and Gschwendt, M. (1995) Protein kinase Cδ-specific phosphorylation of the elongation factor eEF-1a and an eEF-1a peptide at threonine 431. J. Biol. Chem. 270, 6156-6162
230. Ways, K. D., Cook, P. P., Webster, C., and Parker, P. J. (1992) Effect of phorbol esters on protein kinase C-ζ. J. Biol. Chem. 267, 4799-4805
231. Gschwendt, M., Kittstein, W., and Marks, F. (1991) Protein kinase C activation by phorbol esters: do cysteine-rich regions and pseudosubstrate motifs play a role? Trends Biochem. Sci. 16, 167-169
232. Orr, J. W., Keranen, L. M., and Newton, A. C. (1992) Reversible exposure of the pseudosubstrate domain of protein kinase C by phosphatidylserine and diacylglycerol. J. Biol. Chem. 167, 15263-15266
233. Lehel, C., Olah, Z., Jakab, G., Szallasi, Z., Petrovics, G., Harta, G., Blumberg, P. M., and Anderson, W. B. (1995) Protein kinase C ε subcellular localization domains and proteolytic degradation sites. A model for protein kinase C conformational changes. J. Biol. Chem. 270, 19651-19658
234. Leventhal, P. S., and Bertics, P. J. (1993) Activation of protein kinase C by selective binding of arginine-rich peptide. J. Biol. Chem. 268, 13906-13913
235. Newton, A.C. (1995) Protein kinase C: structure, function, and regulation. J. Biol. Chem. 270, 28495-28498
236. House, C., and Kemp, B. E. (1990) Protein kinase C pseudosubstrate prototyp: structure-function relationships. Cell. Signalling 2, 187-190
237. Eichholtz, T., Alblas, J., van Overveld, M., Moolenaar, W., and Ploegh, H. (1990) A pseudosubstrate peptide inhibits protein kinase C-mediated phosphorylation in permeabilized Rat-1 cells. FEBS Lett. 261, 147-150
238. Eichholtz, T., de Bont, D. B. A., de Widt, J., Liskamp, R. M. J., and Ploegh, H. L. (1993) A myristoylated pseudsubstrate peptide, a novel protein kinase C inhibitor. J. Biol. Chem. 268, 1982-1986
239. Ward, N. E., Gravitt, K. R., and O'Brian, C. A. (1995) Irreversible inactivation of protein kinase C by a peptide-substrate analog. J. Biol. Chem. 270, 8056-8060
240. O'Brian, C. A., Ward, N. E., Liskamp, R. M., deBont, D. B., and van Boom, J. H. (1990) N-myristyl-Lys-Arg-Thr-Leu-Arg: a novel protein kinase C inhibitor. Biochem. Pharmacol. 39, 49-57
241. Ward, N. E., Gravitt, K. R., and O'Brian, C. A. (1995) Inhibition of protein kinase C by a synthetic peptide corresponding to cytoplasmic domain residues 828-848 of the human immunodeficiency virus type 1 envelope glycoprotein. Cancer Lett. 88, 37-40
242. Su, H., Kemp, B., Turner, S. R., and Kuo, J. F. (1986) Synthetic myelin basic protein peptide analogs are specific inhibitors of phospholipid/calcium-dependent protein kinase (protein kinase C). Biochem. Biophys. Res. Commun. 134, 78-84
243. Malinow, R., Schulman, H., and Tsien, R. W. (1989) Inhibition of postsynaptic PKC or CaMKII blocks induction but not expression of LTP. Science 245, 862-866
244. Barja, P., Alavi-Nassab, A., Turck, C. W., and Freire-Moar, J. (1994) Inhibition of T cell activation by protein kinase C pseudosubstrates. Cell. Immunol. 153, 28-38
245. Berg, J. M. (1990) Zinc fingers and other metal-binding domains. J. Biol. Chem. 265, 6513-6516
246. Parker, P. J., Mitchell, F., Stabel, S., Marais, R., Ullrich, A., and Goris, J. (1987) Phosphorylation of protein kinase C. Adv. Prot. Phosphatases 4, 363-373
247. Patel, G., and Stabel, S. (1989) Expression of a functional protein kinase C-γ using a baculovirus vector: purification and characterization of a single protein kinase C iso-enzyme. Cell. Signalling 1, 227-240
248. Borner, C., Filipuzzi, I., Wartmann, M., Eppenberger, U., and Fabbro, D. (1989) Biosynthesis and posttranslational modifications of protein kinase C in human breast cancer cells. J. Biol. Chem. 264, 13902-13909
249. Zhang, J., Wang, L., Schwartz, J., Bond, R. W., and Bishop, W. R. (1994) Phosphorylation of Thr-642 is an early event in the processing of newly synthesized protein kinase Cβ1 and is essential for its activation. J. Biol. Chem. 269, 19578-19584
250. Dutil, E. M., Keranen, L. M., DePaoli-Roach, A. A., and Newton, A. C. (1994) In vivo regulation of protein kinase C by transphosphorylation followed by autophosphorylation. J. Biol. Chem. 269, 29359-29362
251. Keranen, L. M., Dutil, E. M., and Newton, A. C. (1995) Protein kinase C is regulated in vivo by three functionally distinct phosphorylations. Curr. Biol. 5, 1393-1403
252. Orr, J. W., and Newton, A. C. (1994) Requirement for negative charge on "activation loop" of protein kinase C. J. Biol. Chem. 269, 27715-27718
253. Cazaubon, S., Bornancin, F., and Parker, P. J. (1994) Threonine-497 is a critical site for permissive activation of protein kinase Cα. Biochem. J. 301, 443-448
254. Li, W., Li, W., Chen, X. H., Kelley, C. A., Alimandi, M., Zhang, J., Chen, Q., Bottaro, D. P., and Pierce. J. H. (1996) Identification of tyrosine 187 as a protein kinase C-δ phosphorylation site. J. Biol. Chem. 271, 26404-26409
255. Gysin, S., and Imber, R. (1996) Replacement of Ser657 of protein kinase C-α by alanine leads to premature down regulation after phorbol-ester-induced translocation to the membrane. Eur. J. Biochem. 240, 747-750
256. Kazanietz, M. G., Areces, L. B., Bahador, A., Mischak, H., Goodnight, J., Mushinski, F. J., and Blumberg, P. M. (1993) Characterization of ligand and substrate specificity for the calcium-dependent and calcium-independent protein kinase C isozymes. Mol. Pharmocol. 44, 298-307